| Product Code: ETC7638759 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland`s import of pyruvate kinase saw a significant increase in concentration with the top exporting countries being the USA, Lithuania, Israel, Japan, and Mexico. The market witnessed a high growth rate of 72.65% from 2023 to 2024, reflecting a booming demand for this product. With a impressive compound annual growth rate (CAGR) of 45.23% from 2020 to 2024, the pyruvate kinase market in Ireland is showing promising opportunities for international suppliers. The shift towards high concentration in 2024 indicates a growing competitiveness among exporters vying for a share in Ireland`s market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Pyruvate Kinase Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Pyruvate Kinase Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Pyruvate Kinase Market - Industry Life Cycle |
3.4 Ireland Pyruvate Kinase Market - Porter's Five Forces |
3.5 Ireland Pyruvate Kinase Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Ireland Pyruvate Kinase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pyruvate kinase deficiency in Ireland |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of pyruvate kinase disorders |
4.2.3 Technological advancements leading to improved diagnostic capabilities in the field of pyruvate kinase disorders |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals with expertise in pyruvate kinase disorders |
4.3.2 High cost associated with diagnostic tests and treatment for pyruvate kinase deficiency |
4.3.3 Regulatory challenges and stringent approval processes for new pyruvate kinase therapies |
5 Ireland Pyruvate Kinase Market Trends |
6 Ireland Pyruvate Kinase Market, By Types |
6.1 Ireland Pyruvate Kinase Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Ireland Pyruvate Kinase Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Ireland Pyruvate Kinase Market Revenues & Volume, By Pyrukynd (Mitapivat), 2021- 2031F |
6.1.4 Ireland Pyruvate Kinase Market Revenues & Volume, By RPL301, 2021- 2031F |
7 Ireland Pyruvate Kinase Market Import-Export Trade Statistics |
7.1 Ireland Pyruvate Kinase Market Export to Major Countries |
7.2 Ireland Pyruvate Kinase Market Imports from Major Countries |
8 Ireland Pyruvate Kinase Market Key Performance Indicators |
8.1 Average age of diagnosis for pyruvate kinase deficiency in Ireland |
8.2 Number of research studies and clinical trials focused on pyruvate kinase disorders in Ireland |
8.3 Adoption rate of new diagnostic technologies for pyruvate kinase deficiency in Irish healthcare facilities |
9 Ireland Pyruvate Kinase Market - Opportunity Assessment |
9.1 Ireland Pyruvate Kinase Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Ireland Pyruvate Kinase Market - Competitive Landscape |
10.1 Ireland Pyruvate Kinase Market Revenue Share, By Companies, 2024 |
10.2 Ireland Pyruvate Kinase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here